Ribon Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, focused on developing innovative therapies that target RNA biology to treat various diseases. The company specializes in the discovery and development of small molecule therapeutics aimed at modulating RNA processes, with a particular emphasis on oncology and other serious health conditions. Ribon's research leverages advanced scientific insights to create novel treatment options, positioning the company at the forefront of RNA-targeted drug development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

12 Patents

#204 in Cambridge, MA

#1,545 in Massachusetts

#25,540 in US

#48,129 in the World

Cambridge, MA, United States of America

Ribon Therapeutics, Inc.

Forward Citations = 34

11 inventors:

Melissa Marie Vasbinder (12 out of 12 patents)

Kevin Wayne Kuntz (12 out of 85 patents)

Laurie B Schenkel (10 out of 26 patents)

4. Kerren Kalai Swinger (9 out of 14 patents)

5. Nicholas Robert Perl (3 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ribon Therapeutics, Inc.. Retrieved from https://idiyas.com/company/ribon-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]